Computed Properties
Complexity:
634
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1
Defined Atom Stereocenter Count:
1
Defined Bond Stereocenter Count:
0
Exact Mass:
361.144g/mol
Formal Charge:
0
Heavy Atom Count:
26
Hydrogen Bond Acceptor Count:
8
Hydrogen Bond Donor Count:
1
Isotope Atom Count:
0
Molecular Weight:
361.373g/mol
Monoisotopic Mass:
361.144g/mol
Rotatable Bond Count:
2
Topological Polar Surface Area:
73.3A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
XLogP3:
-0.4
Synonyms
Anhydrous, Levofloxacin
Levaquin
Cravit
AC1L3YF8
SCHEMBL15397
BSPBio_002689
KBioGR_001605
KBioSS_002199
fluoro-methyl-(4-methylpiperazin-1-yl)-oxo-[?]carboxylic acid
MLS000759524
MLS001165709
MLS001423977
SPECTRUM1504260
Iquix
SPBio_001891
DTXSID0041060
KBio2_002199
KBio2_004767
KBio2_007335
KBio3_001909
BIL1009
EBD8264
GSDSWSVVBLHKDQ-JTQLQIEISA-N
ZX-AFC000651
Levofloxacine
HMS1922J07
HMS2051G04
HMS2090O10
HMS2093E18
HMS2232G06
Pharmakon1600-01504260
ZINC538273
BCP22048
EX-A1488
HY-B0330
Tavanic
Levofloxacin, >=98.0% (HPLC)
BDBM50366826
BG0235
CCG-39093
DE-108
MMV687798
NSC758709
s1940
AKOS008901361
AKOS015895104
(-)-Ofloxacin
AC-7593
AN-8873
API0007780
CS-2218
DB01137
MCULE-2011834955
NC00094
NSC-758709
NCGC00178529-01
NCGC00178529-03
Ofloxacin S-(-)-form
(-)-(S)-9-fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7H-pyridol[1,2,3-de]-1,4-benzoxazine-6-carboxylic acid hemihydrate
(-)-(S)-9-fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7Hpyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic acid hemihydrate
AJ-23383
AS-31796
LVX
SAM001246758
Levofloxacin, analytical reference material
SBI-0206768.P001
AB0072147
AB1009501
(S)-Ofloxacin
LS-133260
LS-171761
FT-0627808
L0193
ST24047487
C07660
D08120
AB00171657-12
AB00171657-13
AB00171657_14
Levofloxacino
AB00171657_15
986L854
SR-05000001999
Levofloxacin, Antibiotic for Culture Media Use Only
SR-05000001999-1
BRD-K09471561-001-06-7
Z1766089137
UNII-A4P49JAZ9H component GSDSWSVVBLHKDQ-JTQLQIEISA-N
Levofloxacin solution, 1.0 mg/mL in acetonitrile, certified reference material
(-)-Ofloxacin; (-)-(S)-9-Fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazin-yl)-7-oxo-7H-pyrido(1,2,3-de)-1,4-benzoxazine-6-carboxylic acid
Levofloxacinum
(2S)-7-fluoro-2-methyl-6-(4-methylpiperazin-1-yl)-10-oxo-4-oxa-1-azatricyclo[7.3.1.0;{5,13}]trideca-5(13),6,8,11-tetraene-11-carboxylic acid
(2S)-7-fluoro-2-methyl-6-(4-methylpiperazin-1-yl)-10-oxo-4-oxa-1-azatricyclo[7.3.1.0^{5,13}]trideca-5(13),6,8,11-tetraene-11-carboxylic acid
(S)-(-)-9-fluoro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-2,3-dihydro-7H-pyrido[1,2,3-de][1,4]benzooxazine-6-carboxylic acid
(S)-9-fluoro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-2,3-dihydro-7H-pyrido[1,2,3-de][1,4]-benzoxazine-6-carboxylic acid
7H-Pyrido(1,2,3-de)-1,4-benzoxazine-6-carboxylic acid, 2,3-dihydro-9-fluoro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-, hemihydrate, (S)-
LVFX; RWJ 25213; L-Ofloxacin; Ophthalmic; (-)-(S)-9-Fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazin-yl)-7-oxo-7H-pyrido(1,2,3-de)-1,4-benzoxazine-6-carboxylic acid
ofloxacin
d-Levofloxacin
R-Ofloxacin
Floxin
Elequine
Not Available
FLUOROQUINOLONE
Levofloxacin Anhydrous
Oftaquix (TN)
Tavanic (TN)
Quixin (TN)
Levofloxacin Hemihydrate
Iquix (TN)
Anhydrous, Levofloxacin
Ofloxacin, (S)-Isomer
Levofloxacin
Oftaquix
CHEMBL33
D02RSN
DR 3354
Levofloxacin, 98% - 25G 25g
C18-H20-F-N3-O4
CID149096
ACN-038325
CS-O-01741
A5511
B1959
L-Ofloxacin
D064704
(S)-9-fluoro-3-methyl-10-(4-methylpiperazin-1-yl)-7-oxo-3,7-dihydro-2H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid
8-Fluoro-3-methyl-9-(4-methyl-piperazin-1-yl)-6-oxo-2,3-dihydro-6H-1-oxa-3a-aza-phenalene-5-carboxylic acid
82419-36-1
Floxacin
(S)-(-)-Ofloxacin
DR-3355
Levofloxacine [INN-French]
Levofloxacinum [INN-Latin]
Levofloxacino [INN-Spanish]
DR3355
HR 355
Levofloxacin Anhydrous
Levofloxacin [USAN:INN:JAN]
Levofloxacin hydrate
RWJ 25213-097
UNII-RIX4E89Y14
MP-376
RWJ-25213
CCRIS 4074
Levofloxacin (Levaquin)
Levaquin (TN)
LEVAQUIN IN DEXTROSE 5% IN PLASTIC CONTAINER
Ofloxacin, (S)-Isomer
RIX4E89Y14
(3S)-9-fluoro-3-methyl-10-(4-methylpiperazin-1-yl)-7-oxo-2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid
(S)-9-Fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7H-pyrido(1,2,3-de)-1,4-benzoxazine-6-carboxylic acid
CHEBI:63598
CPD000466387
(-)-(S)-9-Fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7H-pyrido(1,2,3-de)-1,4-benzoxazine-6-carboxylic acid
(S)-9-fluoro-3-methyl-10-(4-methylpiperazin-1-yl)-7-oxo-2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid
LFX
Q-201295
Aeroquin
Quixin
Leroxacin
Lesacin
Levokacin
Levoxacin
Mosardal
Nofaxin
Reskuin
Unibiotic
Venaxan
Volequin
LEVOFLOXACIN
Floxel
Levox
Loxof
138199-71-0
Cravit Ophthalmic
C18H20FN3O4.H2O
()-(S)-9-Fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7H-pyrido[1,2,3-de]-1;()-(S)-9-Fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7H-pyrido[1,2,3-de]-1
(3S)-(-)-9-Fluoro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-2,3-dihydro-7H-pyrido[1,2,3-de][1,4]benzoxazine-6-carboxylic acid
7H-Pyrido(1,2,3-de)-1,4-benzoxazine-6-carboxylic acid, 2,3-dihydro-9-fluoro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-, (S)-
7H-Pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic acid, 9-fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-, (3S)-
100986-85-4
SMR000466387
(R)-isomer
Cravit (TN)
Levofloxacin (INN)
S-(-)-Ofloxacin
CCRIS 4073
C18H20FN3O4
Levofiexacin
Cravit hydrate
Iquix hydrate
Levaquin
Levaquin hydrate
Levo Floxacin
MFCD00865049
HSDB 8028
Cravit IV
Levofloxacin,(S)
DR-3355: L-isomer of ofloxacin
(3s)-9-fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7h-pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic acid
(R)-9-Fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7H-pyrido(1,2,3-de)-1,4-benzoxazine-6-carboxylic acid
AK163316
Quixin
DRG-0129
levofloxacin-levaquin
HR-355
MP 376
Spectrum_001719
Spectrum2_001676
Spectrum3_000995
Spectrum4_001123
Spectrum5_001438
Levofloxacin tablet, suspension or intravenous
